Ron Bentsur - 15 Aug 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
15 Aug 2023
Net transactions value
+$5,112
Form type
4
Filing time
16 Aug 2023, 16:05:10 UTC
Previous filing
11 Aug 2023
Next filing
06 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $3,370 +235 +0.01% $14.34 3,232,429 15 Aug 2023 Direct F1, F2
transaction NVCT Common Stock Purchase $1,742 +115 +0% $15.15 3,232,544 16 Aug 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.25 to $14.44. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 426,759 shares of restricted stock.